137 related articles for article (PubMed ID: 17202812)
1. Vinblastine, a chemotherapeutic drug, inhibits palmitoylation of tubulin in human leukemic lymphocytes.
Caron JM; Herwood M
Chemotherapy; 2007; 53(1):51-8. PubMed ID: 17202812
[TBL] [Abstract][Full Text] [Related]
2. Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines.
Mulligan JM; Greene LM; Cloonan S; Mc Gee MM; Onnis V; Campiani G; Fattorusso C; Lawler M; Williams DC; Zisterer DM
Mol Pharmacol; 2006 Jul; 70(1):60-70. PubMed ID: 16571652
[TBL] [Abstract][Full Text] [Related]
3. Tubulin as a major cell surface protein in human lymphoid cells of leukemic origin.
Rubin RW; Quillen M; Corcoran JJ; Ganapathi R; Krishan A
Cancer Res; 1982 Apr; 42(4):1384-9. PubMed ID: 6949640
[TBL] [Abstract][Full Text] [Related]
4. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the effects of vinblastine, vincristine, vindesine, and vinepidine on microtubule dynamics and cell proliferation in vitro.
Jordan MA; Himes RH; Wilson L
Cancer Res; 1985 Jun; 45(6):2741-7. PubMed ID: 3986806
[TBL] [Abstract][Full Text] [Related]
6. Interaction of 4-arylcoumarin analogues of combretastatins with microtubule network of HBL100 cells and binding to tubulin.
Rappl C; Barbier P; Bourgarel-Rey V; Grégoire C; Gilli R; Carre M; Combes S; Finet JP; Peyrot V
Biochemistry; 2006 Aug; 45(30):9210-8. PubMed ID: 16866367
[TBL] [Abstract][Full Text] [Related]
7. [Biological characteristics of microtubule and related drug research].
Li JN; Jiang JD
Yao Xue Xue Bao; 2003 Apr; 38(4):311-5. PubMed ID: 12889136
[No Abstract] [Full Text] [Related]
8. Effect of drugs affecting microtubular assembly on microtubules, phospholipid synthesis and physiological indices (signalling, growth, motility and phagocytosis) in Tetrahymena pyriformis.
Kovács P; Csaba G
Cell Biochem Funct; 2006; 24(5):419-29. PubMed ID: 15912561
[TBL] [Abstract][Full Text] [Related]
9. Comparison of beta-tubulin mRNA and protein levels in 12 human cancer cell lines.
Hiser L; Aggarwal A; Young R; Frankfurter A; Spano A; Correia JJ; Lobert S
Cell Motil Cytoskeleton; 2006 Jan; 63(1):41-52. PubMed ID: 16362954
[TBL] [Abstract][Full Text] [Related]
10. Posttranslational modification of tubulin by palmitoylation: I. In vivo and cell-free studies.
Caron JM
Mol Biol Cell; 1997 Apr; 8(4):621-36. PubMed ID: 9247643
[TBL] [Abstract][Full Text] [Related]
11. The influence of etoposide on the distribution of tubulin in human leukemia cell line HL-60.
Grzanka A; Grzanka D
Med Sci Monit; 2003 Jan; 9(1):BR66-9. PubMed ID: 12552240
[TBL] [Abstract][Full Text] [Related]
12. Resistance to microtubule-targeted cytotoxins in a K562 leukemia cell variant associated with altered tubulin expression and polymerization.
Dumontet C; Jaffrezou JP; Tsuchiya E; Duran GE; Chen KG; Derry WB; Wilson L; Jordan MA; Sikic BI
Bull Cancer; 2004 May; 91(5):E81-112. PubMed ID: 15568225
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the regulation of tubulin by vinblastine.
Gigant B; Wang C; Ravelli RB; Roussi F; Steinmetz MO; Curmi PA; Sobel A; Knossow M
Nature; 2005 May; 435(7041):519-22. PubMed ID: 15917812
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
15. [The regulation of tubulin by vinblastine].
Gigant B; Wang C; Ravelli R; Knossow M
Med Sci (Paris); 2005 Oct; 21(10):814-5. PubMed ID: 16197897
[No Abstract] [Full Text] [Related]
16. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
17. [In vitro study of tubulin polymerisation. Effects of ATP, vinblastine and isaxonine (author's transl)].
Coelho R; Istin M
Nouv Presse Med; 1982 Apr; 11(16):1227-32. PubMed ID: 6896570
[TBL] [Abstract][Full Text] [Related]
18. Reversal of P-glycoprotein-mediated multidrug resistance by cholesterol derived from low density lipoprotein in a vinblastine-resistant human lymphoblastic leukemia cell line.
Shu Y; Liu H
Biochem Cell Biol; 2007 Oct; 85(5):638-46. PubMed ID: 17901905
[TBL] [Abstract][Full Text] [Related]
19. Immuno-histochemical demonstration of alpha-tubulin distribution in rat incisor ameloblasts after vinblastine administration.
Yamamoto T; Sawada T; Onizawa T
Bull Tokyo Dent Coll; 1997 Aug; 38(3):195-9. PubMed ID: 9566134
[TBL] [Abstract][Full Text] [Related]
20. Interaction of a new bis-indol derivative, KAR-2 with tubulin and its antimitotic activity.
Orosz F; Kovács J; Löw P; Vértessy BG; Urbányi Z; Acs T; Keve T; Ovádi J
Br J Pharmacol; 1997 Jul; 121(5):947-54. PubMed ID: 9222552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
